Sales of first big COVID-19 drug, remdesivir, may disappoint - analysis
"A lot of people were worried about the supply and wanted to keep remdesivir for their worst-case patients."
A LAB technician works on investigational coronavirus disease treatment drug Remdesivir at Eva Pharma Facility in Cairo, Egypt, in June(photo credit: AMR ABDALLAH DALSH / REUTERS)
